Skip to main content

Neil Oliver & Bret Weinstein on COVID, Truth, and Human Resilience

Bret WeinsteinJune 2, 20221h 23min209,402 views
21 connections·40 entities in this video

The COVID Response and Its Consequences

  • 💡 The initial COVID response was perceived as an inappropriate "slanging match" rather than a reasoned argument, leading to a feeling of threat and coercion.
  • ⚠️ The rapid shift from advice to coercive instruction, backed by shaming rhetoric, triggered a physiological response of danger for many.
  • 🎯 The emergency use authorization for new medical interventions was contingent on the absence of alternatives, which was questioned given the availability of repurposed drugs.

Repurposed Medicines and Scientific Integrity

  • 🔬 Tess Lawrie is highlighted for her work on ivermectin, including a meta-analysis and uncovering evidence of corruption in studies that questioned its efficacy.
  • 🔍 The modification of RNA in mRNA vaccines and its implications for continuous spike protein production were discussed as critical, undisclosed information.
  • 🚫 The unavailability and taboo surrounding ivermectin suggested a motive to push more profitable vaccines, rather than a lack of efficacy.

The Revealer of Character

  • 🤝 The pandemic experience, though distressing, led to an unlikely gathering and profound connections among individuals who questioned the official narrative.
  • 🎭 Many individuals, like Tess Lawrie, were
Knowledge graph40 entities · 21 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover · drag to explore
40 entities
Chapters20 moments

Key Moments

Transcript312 segments

Full Transcript

Topics15 themes

What’s Discussed

COVID-19Pandemic ResponseIvermectinmRNA VaccinesTess LawrieAndrew HillEmergency Use AuthorizationScientific IntegrityRepurposed MedicinesPlato's CaveHuman ResilienceTruthJournalismArchaeologyHistory
Smart Objects40 · 21 links
People· 10
Events· 4
Products· 3
Companies· 5
Medias· 5
Concepts· 13